Phase 3CompletedAge-related condition
Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis
Phase III Clinical Trial to Evaluate the Efficacy and Safety of Chondroitin Sulfate and Glucosamine Sulfate in Combination Versus Placebo in Patients With Osteoarthritis of the Knee
- Sponsor
- Tedec-Meiji Farma, S.A. (Industry)
- Enrollment
- 158 enrolled
- Conditions
- Knee Osteoarthritis
- Interventions
- CS+SG; Placebo
- Ages
- adults, older adults
- Registry
- NCT01893905, EUCTR2013-000444-26
Full record on ClinicalTrials.gov
From the registry
The main objective is to assess the efficacy of a new formulation containing chondroitin sulfate and glucosamine sulfate (CS+GS) compared with placebo in patients with primary osteoarthritis of the knee.
Primary outcomes
- Change in Pain According to VAS (0-100 mm)
History
Results first posted
Last registry update
Primary completion
Registered
Started
Papers citing this trial
- Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Arthritis & rheumatology (Hoboken, N.J.)